Events & Presentations

Jefferies London Healthcare Conference

This year marks the 10th anniversary of now the largest healthcare-dedicated conference in Europe. The two-day event will include concurrent tracks of company presentations, thematic panel discussions, and 1x1/small-group meetings. This global gathering of leading healthcare executives and institutional, private equity and venture capital investors will address near- and long-term investment opportunities and discuss the mechanisms driving global healthcare.  

Kamada to support and attend the Rabies In The America (RITA) conference

RITA is an international scientific meeting that has been held annually since 1990, the focus of which is the presentation and discussion of developments in rabies research, surveillance, control and prevention. The RITA conference provides unparalleled opportunities for learning of the latest developments in the field of rabies. Kamada, as a committed company involved in Rabies treatment,  is serving as a sponsor to this important meeting, and will have a booth at the conference exhibition.

Kamada to present at 2019 CANTOR GLOBAL HC CONFERENCE

The conference is a three-day multitrack event, which will feature over 200 innovative industry leaders from public and private companies for an in-depth discussion of the developments and trends shaping biotechnology, specialty pharmaceuticals, medical technology, healthcare facilities and services, and life sciences tools and diagnostics. Amir London, Chief Executive Officer, will provide a corporate overview at the 2019 Cantor Global Healthcare Conference, the presentation will take place on Friday, October 4, at 10:05 am ET.

Kamada to participate at the ERS Congress

Welcoming over 20,000 delegates every year, the annual ERS Congress is a showcase of excellence across the entire field of respiratory medicine. The main theme for this year's annual Congress is prevention. Within this theme, there are three main topic areas that the event will focus on. These are: smoking cessation, including e-cigarettes and heated tobacco products; air pollution, such as the effects of air pollution on lung health and childhood lung disease prevention; and vaccination, with infectious diseases being a key driver of exacerbation for many chronic lung diseases. ERS Congress 2019 will also examine the new and exciting areas of scientific research across all lung diseases, and the results and outcomes that this research has provided, as well as presenting new educational tools and resources.

Kamada to participate at the 19th Congress of the European Society for Organ Transplantation (ESOT)

The ESOT2019 Congress in Copenhagen is the largest and most important congress for transplantation professionals in Europe. The congress covers all areas of transplantation and is presented in a programme developed by world leading transplant physicians, surgeons and scientists. The European Society for Organ Transplantation (ESOT) is the umbrella organisation under which all European transplant activities are organised. ESOT trains and supports its members through an extensive educational programme and encourages excellence through its Awards & Grants programme.  

Kamada management to host an investment community conference call on August 6 2019

The company will release financial results for Second Quarter and First Six Months of 2019 prior to the open of the U.S. financial markets on Tuesday, August 06, 2019. Kamada management will host an investment community conference call on Tuesday, August 06, 2019 08:30 Eastern Time to discuss these results and answer questions. Investors Dial:  877-407-0792 International Investors Dial:  201-689-8263 Investors in Israel Dial: 1 809 406 247 Conference ID: 13692291 Click here to enter the call

Kamada to support the 28th Annual Alpha-1 National Conference

The Alpha-1 National Conference is the largest annual gathering of Alphas, their families, leading healthcare professionals and industry in the world. It is a three day event with educational programs given by national experts and leaders in the Alpha-1 field.

Kamada to participate in Jefferies 2019 Healthcare Conference

Following the success of last year’s event, with 400 participating companies and over 2,600 attendees, the conference will again feature an extensive range of public & private healthcare companies across the Biopharmaceuticals, Life Sciences, Healthcare Services, Healthcare IT and Medical Technology sectors. This global gathering of leading executives, institutional investors, private equity investors and VCs will address near- and long-term investment opportunities and discuss the mechanisms driving healthcare in the U.S. and internationally.

Kamada to present at BIO international convention 2019

The BIO International Convention (BIO) attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. The conference brings together a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell. Kamada’s presentation, delivered by CEO Amir London,  will take place on Wednesday, June 5, 2:30 PM, Theater 2.

Kamada to participate in ATC 2019

Join over 4,000 of your fellow professionals in Boston for the must-attend event for professionals involved in transplantation. ATC presents cutting-edge science that covers all organ types and offers insight into the future of the field and patient care.